Coffee Can Portfolio US Stocks — Consistent Revenue Growth and ROCE for Buy and Hold Forever

ROCE above 15%, ROE above 15%, revenue growth above 10%, net margin above 10% — the qualities Robert Kirby identified in stocks you buy and forget for a decade.

Stocks Found: 7
Updated: Daily
Data Source: StockSifting DB

About This Screen

Robert Kirby coined 'Coffee Can Portfolio' in a 1984 paper describing a client whose husband had purchased high-quality stocks, put them in a metaphorical coffee can, and forgotten about them for a decade. When she finally opened the can, the portfolio had outperformed significantly — largely because she hadn't traded away the best compounders based on short-term concerns. Kirby's insight: great businesses left alone compound better than most active management.

WHAT THIS SCREEN FINDS: US NYSE and NASDAQ stocks with ROCE above 15%, ROE above 15%, revenue growth above 10%, and net margin above 10% — all four simultaneously. These four metrics together identify businesses with genuine competitive advantages that are growing consistently and translating that growth into high returns on capital and strong profit margins.

Filter: ROCE > 15% AND ROE > 15% AND Revenue Growth > 10% AND Net Margin > 10% | Sorted by market cap descending

KEY METRICS EXPLAINED: ROCE above 15% confirms genuine capital efficiency. ROE above 15% confirms strong shareholder returns. Revenue growth above 10% confirms active business expansion. Net margin above 10% confirms the growth translates into real profit, not just top-line expansion. Companies meeting all four are the minority of US public companies — truly excellent businesses.

WHY INVESTORS USE IT: Most wealth in equities is created not by trading actively but by holding quality compounders through full market cycles. Amazon, Apple, and similar multi-decade compounders spent most of their existence below the market's radar of 'exciting' stocks — they just kept compounding at high rates. This screen identifies the current generation of potential long-term compounders before they become household names.

BENEFITS: All four criteria simultaneously ensures genuine multi-dimensional quality. Revenue growth confirms the business is actively expanding, not just harvesting old profits. High margins alongside high ROCE is extremely rare — typically reserved for businesses with durable moats. These stocks are designed to be held 5–10+ years, minimizing transaction costs and tax drag.

RISKS AND LIMITATIONS: Quality comes at a price — most stocks on this screen trade at premium valuations. High current metrics don't guarantee future performance; competitive dynamics change and disruption can erode even the strongest moats. A diversified Coffee Can approach (15–20 names) performs better than concentrated bets. Patience is required — multi-year holding periods are necessary for the compounding effect to manifest.

HOW TO ANALYZE STOCKS FROM THIS SCREEN: Check consistency of all four metrics over 5+ years, not just the latest year. Assess competitive moat — what prevents new entrants from competing away these margins? Review management capital allocation — are high returns being reinvested wisely? Evaluate whether revenue growth is organic or acquisition-driven (organic is more sustainable).

COMMON MISTAKES: Buying at any price because 'quality is worth a premium' — even the best businesses are overpriced at some P/E multiple. Failing to hold through temporary earnings setbacks that don't affect the long-term thesis. Over-concentrating in 3–4 names instead of building a genuine portfolio. Abandoning the strategy during market downturns when these stocks often sell off with the market despite their superior fundamentals.

Related screens: High Quality Compounders (ROCE + revenue growth focus), Winner Stocks (ROCE + ROE + growth triple filter), Consistent 5-Year Earnings (long-term profitability track record), Consistent 3-Year Sales and Profit Growth (revenue and earnings consistency), EBITDA Margin Above 30% (high-margin business quality).

Frequently Asked Questions

What is a Coffee Can Portfolio?

Coined by Robert Kirby in 1984, a Coffee Can Portfolio consists of high-quality stocks bought and held for 10+ years without trading — metaphorically placed in a coffee can and forgotten. Kirby observed that the best long-term wealth creation came from holding quality compounders through all conditions, not from active trading. The strategy minimizes taxes, transaction costs, and behavioral mistakes.

What criteria does the Coffee Can Portfolio screen use?

ROCE above 15%, ROE above 15%, revenue growth above 10%, and net margin above 10% — all four simultaneously. These filters identify genuinely high-quality businesses growing consistently at above-average rates while maintaining excellent capital efficiency and profitability. Meeting all four simultaneously is rare and indicates a durable competitive advantage.

How many years should I hold Coffee Can Portfolio stocks?

The original concept suggests 10+ years. Practically, the minimum holding period to capture the compounding benefit is 5 years. Shorter holding periods introduce trading noise that destroys value. The core insight is that quality compounders perform best when left completely alone — frequent review and rebalancing typically reduces rather than improves returns.

What makes a business a genuine 'compounder'?

A genuine compounder reinvests earnings at high rates of return consistently over many years. The key characteristic is the ability to redeploy capital internally at ROCE above 15% rather than returning it to shareholders or making low-return acquisitions. Warren Buffett describes these as businesses with a 'durable moat' — structural advantages that protect returns from competition.

Should Coffee Can stocks be in a tax-advantaged account?

Yes, ideally. The compounding benefit of buy-and-hold investing is maximized when capital gains taxes are deferred. In a taxable account, the strategy still works — the buy-and-hold approach minimizes turnover and therefore short-term capital gains. Long-term capital gains rates in the US (0-20%) are meaningfully lower than short-term rates, rewarding the patient approach.

How does the Coffee Can screen differ from the High Quality Compounders screen?

Coffee Can requires four simultaneous metrics: ROCE > 15%, ROE > 15%, revenue growth > 10%, net margin > 10%. High Quality Compounders focuses specifically on ROCE and revenue growth combination. Coffee Can is a stricter filter with more conditions — fewer stocks pass, and those that do meet a higher overall quality bar.

Can small-cap stocks be Coffee Can investments?

Yes, though they come with additional risk. Small-cap compounders have historically produced the best long-term returns precisely because they're overlooked by institutional investors. The Coffee Can screen doesn't filter by market cap — it applies quality criteria regardless of size. Smaller positions and longer conviction periods are appropriate for small-cap names on this screen.

What happens when a Coffee Can stock's metrics deteriorate?

The original concept says hold regardless. The practical approach is to do an annual review — if the core metrics (ROCE, ROE, revenue growth, margins) have meaningfully deteriorated for structural rather than cyclical reasons, that's the signal to exit. Temporary earnings setbacks in otherwise quality businesses should be held through, not traded away.

Which sectors dominate Coffee Can Portfolio screens?

Technology (particularly software and SaaS), healthcare (specialty pharmaceuticals and diagnostics), consumer staples (brand-moat consumer goods), and financial services (payment networks, specialty finance) dominate. These sectors combine the revenue growth, margin quality, and capital efficiency the screen requires. Utilities and basic materials rarely qualify.

How do I build a Coffee Can Portfolio using this screen?

Select 15–20 stocks from the screen diversified across at least 5 sectors. Invest equal amounts in each. Hold for a minimum of 5 years without trading. Review annually to confirm core thesis is intact — not to trade on market movements. Rebalance only if a holding drops off the quality metrics for structural reasons, or to add new high-quality names discovered through the screen.

Results 7 stocks matched

Refreshed daily · Sorted by Market Cap (High → Low)

✓ Live Data
S.No. Company Rev Growth % Net Margin % D/E Price P/E Mkt Cap Div Yld % ROCE % ROE % 52W High 52W Low
1. Indivior Pharmaceuticals, Inc. 19.7% 16.95% -3.55 $37.62 21.84 $4.59 B 92.33% 159.06% $41 $13.42
2. Fair Isaac Corporation 16.4% 31.89% -1.76 $1,137.33 35.18 $26.73 B 91.84% 145.71% $1,998.01 $870.01
3. Novavax, Inc. 66.6% 39.19% -1.95 $9.49 3.52 $1.66 B 76.84% 283.08% $11.97 $6.13
4. Booking Holdings Inc. 16% 20.08% -3.46 $165.84 20.78 $127.91 B 1% 73.87% 139.63% $233.58 $150.14
5. MSCI Inc. 10.6% 38.36% -2.38 $615.46 34.37 $45.36 B 1.32% 44.25% 108.67% $644.68 $501.08
6. IRADIMED CORPORATION 17% 26.82% 0 $93.07 50.66 $1.2 B 0.79% 26.52% 24.48% $107.9 $55.11
7. TransDigm Group Incorporated 13.9% 22.24% -3.1 $1,238.74 33.04 $68.8 B 7.69% 20.21% 37.11% $1,623.83 $1,123.61